The IASLC Atlas of PD-L1 Immunohistochemistry Testing in Lung Cancer is designed to help pathologists, clinicians, other health care personnel and patients better understand emerging programmed cell death ligand-1 (PD-L1) immunohistochemistry (IHC) assays as well as important areas of clarity and debate.